Cosmo
07/09/22 19:35
Ha respondido al tema
Farmas USA
PNT si no recuerdo mal, la SPAC de Ra capital, ahora pharma. hace unos días presentó un poster, y cayó. Conjuntamente anuncian otro epostar con updated data este 11 setiembre, no entiendo muy bien la jugada.. si alguien que sepa un poco de ciencia quiere echarle un vistazo... creo que es sobre una fase3.. ojo! no sé si definitivo o que van informando... saludos Framus. ! jajaPoster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. HansenINDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced data will be released at ESMO Congress 2022 in Paris, France about the efficacy and safety of PNT2002 in the lead-in cohort of the SPLASH trial. An abstract is now available on the ESMO congress website at https://cslide.ctimeetingtech.com/esmo2022/attendee/confcal_2/presentation/list?q=1400P, and an e-poster which contains updated data will be published and presented on Sunday, September 11th.